HealthKart raises USD 25 million from Sofina to expand offline network

Published On 2019-05-10 04:35 GMT   |   Update On 2019-05-10 04:35 GMT

HealthKart will use the funds to expand its offline store network, develop additional direct-to-consumer nutrition brands and strengthen its vertical integration.


New Delhi: Omni-channel nutrition platform HealthKart Thursday said it has raised USD 25 million (over Rs 174 crore) from investment firm Sofina in a fresh round of funding. The company will use the funds to expand its offline store network, develop additional direct-to-consumer nutrition brands and strengthen its vertical integration, HealthKart said in a statement.


HealthKart founder and Chief Executive Officer Sameer Maheshwari said, "We are excited to partner with Sofina, who have deep experience in investing in consumer brands, for the next phase of our growth."


Read Also: Alphabet’s GV leads $58.5 million investment to launch Verve Therapeutics


With a strong focus on product development, manufacturing and distribution, the company's mission is to make health and nutrition mainstream and bring best-in-class nutrition solutions to customers, he added.


In a similar vein, Sofina Asia Investment Manager Tanya Sen said, "We look forward to partnering with HealthKart to further expand its brand portfolio and distribution network in the fast-growing nutrition and wellness space in India."


Founded in 2011 by Sameer Maheshwari and Prashant Tandon, HealthKart offers a comprehensive range of nutrition supplements such as proteins, vitamins and herbal supplements, through a combination of online portal and over 110 offline stores spread across 40 cities.


Read Also: Netmeds acquires health tech startup KiViHealth with Rs 70 crore investment commitment

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News